Conversion Labs Announces Official Launch of Men’s Telehealth Brand Rex MD

NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) — Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced its official launch of Rex MD, a male-oriented telemedicine brand.
Customers can now visit where they can be diagnosed and prescribed prescription medications that are discretely delivered to their home.  Rex MD is initially focused on the treatment of erectile dysfunction and will offer additional prescription medications for men in the coming months.Due to trends such as rising internet proficiency, rising healthcare costs, and customer demand for convenience, the global telemedicine market is expected to reach $130 billion by 2025 according to Global Market Insights. Expected to grow at a compounded annual growth rate of over 19%, telemedicine is currently one of the fastest growing segments in healthcare.“We have been preparing to enter the rapidly growing telemedicine space since the beginning of the year,” stated Justin Schreiber, Chairman and CEO of Conversion Labs, Inc. “Our launch of Rex MD represents the culmination of our efforts in creating a robust telemedicine technology infrastructure in addition to receiving the stringent certifications required to operate in this emerging space. Given our company’s core competency in acquiring customers scalably and profitably, we expect great things from our telemedicine launch as Rex MD grows in both market share and presence.”About Conversion LabsConversion Labs, Inc is a health and wellness focused e-commerce company with a portfolio of online direct-to-consumer brands. The company’s portfolio of brands includes proprietary over-the-counter products and prescription medications. The company also provides online, virtual physician consultations to consumers in 48 states. In addition to its healthcare platform, Conversion Labs is the majority shareholder of PDF Simpli, a direct to consumer SaaS business for editing, signing, and sharing PDF documents. To learn more about our corporate strategy, brands, or for investor relations please visit or email us at Statements

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.